Comparison of Oral Contraceptives and Non-Oral Alternatives

Comparison of Oral Contraceptives and Non-Oral Alternatives

PL Detail-Document #290305 −This PL Detail-Document gives subscribers additional insight related to the Recommendations published in− PHARMACIST’S LETTER / PRESCRIBER’S LETTER March 2013 Comparison of Oral Contraceptives and Non-Oral Alternatives —More information about the use of contraceptives is available in our PL Detail-Document, Hormonal Contraception— Productsa Manufacturerb Estrogen Progestin LOW-DOSE MONOPHASIC PILLS Aviane-28 Teva EE 20 mcg Levonorgestrel 0.1 mg Falmina Novast Lessina Teva Lutera Actavis Orsythia Qualitest Sronyx Actavis Gildess Fe 1/20 Qualitest EE 20 mcg Norethindrone acetate Junel 1/20 Teva 1 mg Junel Fe 1/20 Teva Loestrin-21 1/20 Warner Chilcott/Teva Loestrin Fe 1/20 Warner Chilcott/Teva Microgestin 1/20 Actavis Microgestin Fe 1/20 Actavis Generess Fe chewable Actavis EE 25 mcg Norethindrone 0.8 mg Altavera Sandoz EE 30 mcg Levonorgestrel 0.15 mg Kurvelo Lupin Levora Actavis Marlissa Glenmark Nordette-28 Duramed/Teva Portia-28 Teva Cryselle-28 Teva EE 30 mcg Norgestrel 0.3 mg Elinest Novast Low-Ogestrel-21 Actavis Low-Ogestrel-28 Actavis Lo/Ovral-28 Wyeth Gildess Fe 1.5/30 Qualitest EE 30 mcg Norethindrone acetate Junel 1.5/30 Teva 1.5 mg Junel Fe 1.5/30 Teva Loestrin 1.5/30-21 Warner Chilcott/Teva Loestrin Fe 1.5/30 Warner Chilcott/Teva Microgestin 1.5/30 Actavis Microgestin Fe 1.5/30 Actavis More. Copyright © 2013 by Therapeutic Research Center 3120 W. March Lane, Stockton, CA 95219 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.PharmacistsLetter.com ~ www.PrescribersLetter.com ~ www.PharmacyTechniciansLetter.com (PL Detail-Document #290305: Page 2 of 7) Productsa Manufacturerb Estrogen Progestin LOW-DOSE MONOPHASIC PILLS (cont.) Apri Teva EE 30 mcg Desogestrel 0.15 mg Desogen Organon Emoquette Qualitest Ortho-Cept Ortho Reclipsen Actavis Solia Prasco levonorgestrel/ethinyl Lupin EE 30 mcg Drospirenone 3 mg estradiol Ocella Teva Safyralc Bayer Syeda Sandoz Zarah Actavis Yasmin Bayer Kelnor 1/35 Teva EE 35 mcg Ethynodiol diacetate Zovia 1/35 Actavis 1 mg Estarylla Sandoz EE 35 mcg Norgestimate 0.25 mg Mono-Linyah Novast MonoNessa Actavis Norgestimate/ethinyl Glenmark estradiol Ortho-Cyclen-28 Ortho Previfem Qualitest Sprintec Teva Necon 1/50 Actavis Mestranol 50 mcg Norethindrone 1 mg Norinyl 1+50 Actavis Balziva Teva EE 35 mcg Norethindrone 0.4 mg; Briellyn Glenmark total of 8.4 mg/cycle.1 Femcon Fe chewable Warner Chilcott Gildagia Qualitest Ovcon-35 Warner Chilcott Philith Novast Vyfemla Lupin Zenchent Actavis Zeosa chewable Teva Brevicon-28 Actavis EE 35 mcg Norethindrone 0.5 mg; Modicon-28 Ortho total of 10.5 mg/cycle. Necon 0.5/35 Actavis Nortrel 0.5/35 Teva Wera Novast Alyacen 1/35 Glenmark EE 35 mcg Norethindrone 1 mg; Cyclafem 1/35 Qualitest total of 21 mg/cycle.1 Dasetta 1/35 Novast Necon 1/35-28 Actavis Norinyl 1+35-28 Actavis Nortrel 1/35-28 Teva Ortho-Novum 1/35-28 Ortho More. Copyright © 2013 by Therapeutic Research Center 3120 W. March Lane, Stockton, CA 95219 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.PharmacistsLetter.com ~ www.PrescribersLetter.com ~ www.PharmacyTechniciansLetter.com (PL Detail-Document #290305: Page 3 of 7) Productsa Manufacturerb Estrogen Progestin HIGH-DOSE MONOPHASIC PILLS Ovcon-50 Warner Chilcott EE 50 mcg Norethindrone 1 mg Ogestrel 0.5/50-28 Actavis EE 50 mcg Norgestrel 0.5 mg Zovia 1/50-28 Actavis EE 50 mcg Ethynodiol diacetate 1 mg BIPHASIC PILLS Azurette Actavis EE 20 mcg x 21 days, Desogestrel Kariva Teva placebo x 2 days, 10 mcg 0.15 mg x 21 days Mircette Teva x 5 days. Viorele Glenmark Necon 10/11 Actavis EE 35 mcg Norethindrone 0.5 mg x 10 days, 1 mg x 11 days. TRIPHASIC PILLS Estrostep Fe Warner Chilcott EE 20 mcg x 5 days, Norethindrone acetate Tilia Actavis 30 mcg x 7 days, 35 mcg 1 mg x 21 days Tilia Fe Actavis x 9 days Tri-Legest Fe Teva Norgestimate/ethinyl Lupin EE 25 mcg x 21 days Norgestimate estradiol 0.18 mg x 7 days, Ortho Tri-Cyclen Lo Ortho 0.215 mg x 7 days, Tri Lo Sprintec Actavis 0.25 mg x 7 days. Caziant Actavis EE 25 mcg x 21 days Desogestrel Cesia Prasco 0.1 mg x 7 days, Cyclessa Schering-Plough 0.125 mg x 7 days, Velivet Teva 0.15 mg x 7 days. Enpresse Teva EE 30 mcg x 6 days, Levonorgestrel Levonest Novast 40 mcg x 5 days, 30 mcg 0.05 mg x 6 days, Myzilra Qualitest x 10 days. 0.075 mg x 5 days, Trivora Actavis 0.125 mg x 10 days. Total of 1.925 mg/cycle.1 Ortho Tri-Cyclen Ortho EE 35 mcg x 21 days Norgestimate Tri-Estarylla Sandoz 0.18 mg x 7 days, Tri-Linyah Novast 0.215 mg x 7 days, TriNessa Actavis 0.25 mg x 7 days. Tri-Previfem Qualitest Tri-Sprintec Teva Aranelle Teva EE 35 mcg x 21 days Norethindrone Leena Actavis 0.5 mg x 7 days, Tri-Norinyl Actavis 1 mg x 9 days, 0.5 mg x 5 days. Total of 15 mg/cycle.1 Alyacen 7/7/7 Glenmark EE 35 mcg x 21 days Norethindrone Cyclafem 7/7/7 Qualitest 0.5 mg x 7 days, Dasetta 7/7/7 Novast 0.75 mg x 7 days, Nortrel 7/7/7 Teva 1 mg x 7 days. Necon 7/7/7 Actavis Total of 15.75 mg/cycle.1 Ortho-Novum 7/7/7 Ortho More. Copyright © 2013 by Therapeutic Research Center 3120 W. March Lane, Stockton, CA 95219 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.PharmacistsLetter.com ~ www.PrescribersLetter.com ~ www.PharmacyTechniciansLetter.com (PL Detail-Document #290305: Page 4 of 7) Productsa Manufacturerb Estrogen Progestin FOUR-PHASIC Natazia Bayer Estradiol valerate 3 mg x Dienogest 2 days, then 2 mg x 22 none x 2 days, then days, then 1 mg x 2 days, 2 mg x 5 days, then then 2-day pill-free 3 mg x 17 days, then interval. none x 4 days EXTENDED-CYCLE PILLS Lo Loestrin Fe Warner Chilcott EE 10 mcg x 26 days Norethindrone acetate Lo Minastrin Fe chewable Warner Chilcott 1 mg x 24 days Loestrin 24 Fe discontinued Warner Chilcott EE 20 mcg x 24 days Norethindrone acetate Minastrin 24 Fe chewable Warner Chilcott 1 mg x 24 days Amethia Lo Actavis EE 20 mcg x 84 days, Levonorgestrel Ethinyl Lupin 10 mcg x 7 days. 0.1 mg x 84 days estradiol/levonorgestrel LoSeasonique Teva Introvale Sandoz EE 30 mcg x 84 days Levonorgestrel Jolessa Teva 0.15 mg x 84 days Levonorgestrel/ethinyl Lupin estradiol Quasense Actavis Seasonale Teva Amethia Actavis EE 30 mcg x 84 days, Levonorgestrel Seasonique Teva 10 mcg x 7 days. 0.15 mg x 84 days Quartette Teva EE 20 mcg x 42 days, Levonorgestrel 25 mcg x 21 days, 0.15 mg x 84 days 30 mcg x 21 days, then 10 mcg x 7 days Beyazc Bayer EE 20 mcg x 24 days Drospirenone Gianvi Teva 3 mg x 24 days Loryna Sandoz Vestura Actavis Yaz Bayer CONTINUOUS-CYCLE PILLS Amethyst Actavis EE 20 mcg Levonorgestrel 90 mcg (No pill-free interval) PROGESTIN-ONLY PILLSd - “Mini-pill” Camila Teva Not applicable Norethindrone 0.35 mg Errin Teva Heather Glenmark Jolivette Actavis Micronor Ortho Nor-QD Actavis Nora-BE Actavis More. Copyright © 2013 by Therapeutic Research Center 3120 W. March Lane, Stockton, CA 95219 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.PharmacistsLetter.com ~ www.PrescribersLetter.com ~ www.PharmacyTechniciansLetter.com (PL Detail-Document #290305: Page 5 of 7) Productsa Manufacturerb Estrogen Progestin EMERGENCY CONTRACEPTION Ella Actavis Not applicable Ulipristal 30 mg tablet (progesterone receptor modulator) Levonorgestrel Perrigo R and D Not applicable Levonorgestrel Next Choice Actavis 0.75 mg tablets x 2 Plan B Teva (separated by 12 hours) Next Choice One Dose Actavis Not applicable Levonorgestrel Plan B One-Step Teva 1.5 mg tablet x 1 Abbreviations: EE = ethinyl estradiol; IUS = intrauterine system HORMONAL ALTERNATIVES TO ORAL CONTRACEPTION Brand Name Manufacturer Estrogen Progestin Dose/Route Depo-Provera CI Pfizer None Medroxyprogesterone Medroxyprogesterone Sicor acetate 150 mg Acetate Injection3,d Intramuscular (IM) injection in the gluteal or deltoid muscle once every 3 months (13 weeks) Depo-subQ Provera 1044,d,e Pfizer None Medroxyprogesterone acetate 104 mg 0.65 mL (104 mg) subcutaneous (SC) injection into the anterior thigh or abdomen, once every 3 months (12-14 weeks) Mirena6,d,g Bayer None Levonorgestrel 20 mcg/day (IUS) for up to 5 years Nexplanon5,d,f Schering-Plough None Etonogestrel (release rate varies over Implanted subdermally just time) for up to 3 years under the skin at the inner side of the non-dominant arm NuvaRing7 Schering-Plough Ethinyl estradiol Etonogestrel (active form 15 mcg/day of desogestrel) Vaginal ring inserted and left 0.12 mg/day in for 3 weeks and removed for 1 week Ortho Evra9,h,i Ortho Ethinyl estradiol Norelgestromin (active 35 mcg/day form of norgestimate) Transdermal patch applied 200 mcg/day weekly (for 3 weeks, then week 4 is patch-free) Skyla8,d Bayer None Levonorgestrel 14 mcg/day (IUS) (after first 24 days of insertion) for up to 3 years More. Copyright © 2013 by Therapeutic Research Center 3120 W. March Lane, Stockton, CA 95219 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.PharmacistsLetter.com ~ www.PrescribersLetter.com ~ www.PharmacyTechniciansLetter.com (PL Detail-Document #290305: Page 6 of 7) a. This grouping is not an indication of therapeutic equivalence for purposes of substitution as defined by the FDA’s Orange Book.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    7 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us